• Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Eksterne analyser

Nyab: Starting the year with a record order backlog - ABG

NYAB

Dette er en ekstern analyse og afspejler ikke nødvendigvis vores perspektiv eller værdier

Download analyse (PDF)
* We leave our estimates fairly unchanged (EBIT +1-0%)
* But strong order intake in Q1 de-risks 2026 estimates
* We reiterate our fair value range of SEK 6-9 per share

Q1 characterised by strong orders

NYAB performed solidly in a seasonally weaker Q1, with earnings (EUR 1m) fairly in line with our estimates and strong FCF (EUR 5m), despite a bit weaker organic growth (-6%). Due to low absolute levels of earnings in Q1 in general (typically <5% of full-year earnings), we put more emphasis on the order intake, which remained strong. With order growth of 24% and the backlog up 28% y-o-y, we think the company remains well-positioned to deliver on our full-year 2026 expectations.

Estimates relatively unchanged

We keep our EBIT estimates fairly unchanged (+0.6%/0.3%/0.3% on '26e/'27e/'28e) and expect NYAB to deliver 19% EBIT growth in 2026 and 10% in 2027. These assumptions exclude potential positive impacts from the two large ongoing Phase 1 projects that the company expects to convert to Phase 2 later this year (during Q2-Q3). Together, these projects provide substantial upside potential to the order backlog, with a potential total order value of ~EUR 700m (of which 400m-500m relates to NYAB).

9x/8x/7x EV/EBITA '26e/'27e/'28e, 15-20% below key peers

With the share reaction to the report and based on our unchanged estimates, the valuation remains at ~9x/8x/7x EV/EBITA on '26e/'27e/'28e, which is ~15-20% below infrastructure service peers, and ~10-20% below Nordic construction peers, which are expected to deliver fairly similar earnings growth on average. But due to its net cash position and strong cash flow (>100% FCF/EBITA conversion historically), we think NYAB has a better opportunity to scale faster and grow through M&A. And because of the strong orders, we think our 2026 estimates for NYAB have been de-risked, although it still has to execute with good margins, which the company has done historically (6-12% L10Y vs. construction peers at ~3%).